These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16759857)
1. Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta. Amarasinghe KK; Evdokimov AG; Xu K; Clark CM; Maier MB; Srivastava A; Colson AO; Gerwe GS; Stake GE; Howard BW; Pokross ME; Gray JL; Peters KG Bioorg Med Chem Lett; 2006 Aug; 16(16):4252-6. PubMed ID: 16759857 [TBL] [Abstract][Full Text] [Related]
2. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics. Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970 [TBL] [Abstract][Full Text] [Related]
3. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48. Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920 [TBL] [Abstract][Full Text] [Related]
4. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold. Yue EW; Wayland B; Douty B; Crawley ML; McLaughlin E; Takvorian A; Wasserman Z; Bower MJ; Wei M; Li Y; Ala PJ; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP Bioorg Med Chem; 2006 Sep; 14(17):5833-49. PubMed ID: 16769216 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of protein tyrosine phosphatases: next-generation drugs? Bialy L; Waldmann H Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease. Raza A; Sham YY; Vince R Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317 [TBL] [Abstract][Full Text] [Related]
8. Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors. Holsworth DD; Jalaie M; Belliotti T; Cai C; Collard W; Ferreira S; Powell NA; Stier M; Zhang E; McConnell P; Mochalkin I; Ryan MJ; Bryant J; Li T; Kasani A; Subedi R; Maiti SN; Edmunds JJ Bioorg Med Chem Lett; 2007 Jul; 17(13):3575-80. PubMed ID: 17482464 [TBL] [Abstract][Full Text] [Related]
9. Structure-based design of protein tyrosine phosphatase-1B inhibitors. Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305 [TBL] [Abstract][Full Text] [Related]
10. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic. Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735 [TBL] [Abstract][Full Text] [Related]
12. Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors. Anderson M; Andrews DM; Barker AJ; Brassington CA; Breed J; Byth KF; Culshaw JD; Finlay MR; Fisher E; McMiken HH; Green CP; Heaton DW; Nash IA; Newcombe NJ; Oakes SE; Pauptit RA; Roberts A; Stanway JJ; Thomas AP; Tucker JA; Walker M; Weir HM Bioorg Med Chem Lett; 2008 Oct; 18(20):5487-92. PubMed ID: 18815031 [TBL] [Abstract][Full Text] [Related]
13. Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. Moretto AF; Kirincich SJ; Xu WX; Smith MJ; Wan ZK; Wilson DP; Follows BC; Binnun E; Joseph-McCarthy D; Foreman K; Erbe DV; Zhang YL; Tam SK; Tam SY; Lee J Bioorg Med Chem; 2006 Apr; 14(7):2162-77. PubMed ID: 16303309 [TBL] [Abstract][Full Text] [Related]
14. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. Evdokimov AG; Pokross M; Walter R; Mekel M; Cox B; Li C; Bechard R; Genbauffe F; Andrews R; Diven C; Howard B; Rastogi V; Gray J; Maier M; Peters KG Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1435-45. PubMed ID: 17139078 [TBL] [Abstract][Full Text] [Related]
15. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors. Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179 [TBL] [Abstract][Full Text] [Related]
16. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Barf T; Lehmann F; Hammer K; Haile S; Axen E; Medina C; Uppenberg J; Svensson S; Rondahl L; Lundbäck T Bioorg Med Chem Lett; 2009 Mar; 19(6):1745-8. PubMed ID: 19217286 [TBL] [Abstract][Full Text] [Related]
17. Study of triaryl-based sulfamic acid derivatives as HPTPβ inhibitors. Zhang W; Wei Z; Huang G; Xie F; Zheng Z; Li S Bioorg Med Chem; 2020 Dec; 28(23):115777. PubMed ID: 32992253 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I. More SS; Vince R Bioorg Med Chem Lett; 2007 Jul; 17(13):3793-7. PubMed ID: 17513107 [TBL] [Abstract][Full Text] [Related]
19. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR. Deak HL; Newcomb JR; Nunes JJ; Boucher C; Cheng AC; DiMauro EF; Epstein LF; Gallant P; Hodous BL; Huang X; Lee JH; Patel VF; Schneider S; Turci SM; Zhu X Bioorg Med Chem Lett; 2008 Feb; 18(3):1172-6. PubMed ID: 18083554 [TBL] [Abstract][Full Text] [Related]
20. Intramolecular hydrogen bonding in medicinal chemistry. Kuhn B; Mohr P; Stahl M J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]